Acadia Pharmaceuticals Reports First Quarter 2024 Financial Results and Operating Overview

Go back to Acadia Pharmaceuticals Reports First Quarter 2024 Financial Results and Operating Overview
Acadia Pharmaceuticals, Inc. (NASDAQ: ACAD) Delayed: 27.70 +0.12 (0.44%)
Previous Close $27.58    52 Week High $42.49 
Open $27.44    52 Week Low $16.64 
Day High $27.95    P/E N/A 
Day Low $27.40    EPS $-0.42 
Volume 189,496